SCHEMBL4384288

SCHEMBL4384288

COCOc1cc(/C=C/C(=O)OC)c(-c2ccccc2)c(OCOC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.45
HDAC8 Q9BY41 3/20 0.42
EGFR P00533 2/20 0.40
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
IP6K1 Q92551 1/20 0.39
IP6K3 Q96PC2 1/20 0.39
IP6K2 Q9UHH9 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384292 1.00 BACE1 (0.45) BACE1HDAC8EGFRKDM4EKMT2A
SCHEMBL4382816 0.89 KDM4E (0.44) BACE1HDAC8EGFRKDM4ESMN1; SMN2
SCHEMBL4382817 0.89 KDM4E (0.44) BACE1HDAC8EGFRKDM4ESMN1; SMN2
SCHEMBL4383966 0.81 ALDH1A1 (0.40) BACE1HDAC8EGFRKDM4EKMT2A
SCHEMBL4381464 0.78 EGFR (0.40) BACE1EGFRKDM4EKMT2ASMN1; SMN2
SCHEMBL4381463 0.78 EGFR (0.40) BACE1EGFRKDM4EKMT2ASMN1; SMN2
SCHEMBL4393717 0.75 EGFR (0.41) EGFRKDM4EKMT2ACCNCCDK8
SCHEMBL2866502 0.75 EGFR (0.43) HDAC8EGFRKDM4EKMT2ASMN1; SMN2
SCHEMBL4382698 0.74 EGFR (0.42) HDAC8EGFRALDH1A1MAPTNPC1
SCHEMBL4392152 0.73 EGFR (0.45) HDAC8EGFRKDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P BACE1 3031/4885HDAC8 94/4885EGFR 624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.